Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation.
1993
The objectives of this prospective randomized trial were to quantify immunosuppressive effects of cardiopulmonary bypass, to identify mechanisms responsible for postoperative immunosuppression, and to investigate the effects of immunomodulatory intervention on these mechanisms. Sixty patients were studied after cardiopulmonary bypass. Immunomodulatory therapy consisted of the cyclooxygenase inhibitor indomethacin, which blocks the downredulating agent prostaglandin E 2 , and thymopentin, which enhances T-lymphocytic activity
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
71
Citations
NaN
KQI